---
category: news
title: "Vyant Bio Retains Skyline Corporate Communications Group, LLC to Provide Investor Relations Services"
excerpt: "Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders. The Company’s central nervous system (“CNS”) drug discovery platform combines human-derived organoid models of brain disease,"
publishedDateTime: 2022-06-01T22:07:00Z
originalUrl: "https://apnews.com/press-release/globe-newswire/covid-technology-science-health-c5f7db524ac9cd5b1fb7636d28a5e31f"
webUrl: "https://apnews.com/press-release/globe-newswire/covid-technology-science-health-c5f7db524ac9cd5b1fb7636d28a5e31f"
type: article
quality: 24
heat: 24
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Finance
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

secured: "yWTPSMGIDpaKXZrh2G+Y97RW+q5fx9Y/gZP5BWsWPs9OoAT6wU1SO6N5dq6ARgW3fLPLjOzO5SHs5fRZUnrj7K8eb4pOW1n3dtWiT5h9ZkIjnFVsLEFC3qaNPtGqlWO7vgWerBRUAutfbhVFOlU8KD50hpAIX6C6jXQsd5AuTJQGD9SViXJ/S7RBNMHbWleGTDvfqRCP+RXN4Dz8ghxXw+0D995enZRVH3+xXZ+lXu6Axo/0a7R5O+3uXMUuYq44wl6YSvBoHHBRWi/LXTekTgkmw/cWZjqgfUX0+ImXsRCs54Wm1BtPLF9vEG1gaH0sCcSlbLjFB5C+FC272P/D8ij4fx6MJVYsMtnRGYobTVg=;X8wE+mT0k9yJ+/H2DJcOFg=="
---

